• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transglutaminase 2 protects against ischemic stroke.转谷氨酰胺酶 2 可预防缺血性脑卒中。
Neurobiol Dis. 2010 Sep;39(3):334-43. doi: 10.1016/j.nbd.2010.04.018. Epub 2010 May 6.
2
Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.完全敲除转谷氨酰胺酶 2 会导致心搏量减少,以及对缺血产生反应性存活增加的星形胶质细胞。
Neurobiol Dis. 2012 Mar;45(3):1042-50. doi: 10.1016/j.nbd.2011.12.023. Epub 2011 Dec 14.
3
Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.转谷氨酰胺酶2可抵御缺血性损伤,与低氧诱导因子1β相互作用,并减弱低氧诱导因子1信号传导。
FASEB J. 2008 Aug;22(8):2662-75. doi: 10.1096/fj.07-097709. Epub 2008 Mar 28.
4
Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.转谷氨酰胺酶2根据其构象和定位促进或改善缺氧诱导因子信号传导及缺血性细胞死亡。
Biochim Biophys Acta. 2013 Jan;1833(1):1-10. doi: 10.1016/j.bbamcr.2012.10.011. Epub 2012 Oct 17.
5
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.转谷氨酰胺酶 2 通过调节缺氧肿瘤细胞中 caspase 3 和 NF-κB 的活性来抑制细胞凋亡。
Oncogene. 2010 Jan 21;29(3):356-67. doi: 10.1038/onc.2009.342. Epub 2009 Oct 19.
6
Depletion of astrocytic transglutaminase 2 improves injury outcomes.星形胶质细胞转谷氨酰胺酶 2 的耗竭可改善损伤结局。
Mol Cell Neurosci. 2018 Oct;92:128-136. doi: 10.1016/j.mcn.2018.06.007. Epub 2018 Jun 30.
7
Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.细胞质鸟嘌呤核苷酸结合缺陷型转谷氨酰胺酶 2(R580a)增强氧葡萄糖剥夺诱导的细胞死亡。
PLoS One. 2011 Jan 31;6(1):e16665. doi: 10.1371/journal.pone.0016665.
8
Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.转谷氨酰胺酶 2:是敌是友?神经元和星形胶质细胞中的不和谐角色。
J Neurosci Res. 2018 Jul;96(7):1150-1158. doi: 10.1002/jnr.24239. Epub 2018 Mar 23.
9
Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.多柔比星诱导细胞内转谷氨酰胺酶 2 的持续激活,从而防止细胞死亡。
Mol Cells. 2012 Mar;33(3):235-41. doi: 10.1007/s10059-012-2201-9. Epub 2012 Feb 28.
10
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.通过抑制组蛋白脱乙酰酶激活组织转谷氨酰胺酶转录作为Myc致癌作用的一种治疗方法。
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18682-7. doi: 10.1073/pnas.0705524104. Epub 2007 Nov 14.

引用本文的文献

1
Pharmacological Inhibition of Astrocytic Transglutaminase 2 Facilitates the Expression of a Neurosupportive Astrocyte Reactive Phenotype in Association with Increased Histone Acetylation.星形胶质细胞转谷氨酰胺酶2的药理学抑制作用促进了神经支持性星形胶质细胞反应性表型的表达,并伴有组蛋白乙酰化增加。
Biomolecules. 2024 Dec 13;14(12):1594. doi: 10.3390/biom14121594.
2
Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation.星形胶质细胞转谷氨酰胺酶2的药理学抑制作用促进了神经支持性星形胶质细胞反应性表型的表达,并伴有组蛋白乙酰化增加。
bioRxiv. 2024 Nov 11:2024.04.15.589192. doi: 10.1101/2024.04.15.589192.
3
PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α.丙酮酸脱氢酶激酶1(PDK1)通过增强缺氧诱导因子-1α(HIF-1α)的稳定性和转录活性来促进乳腺癌进展。
Genes Dis. 2023 Jul 15;11(4):101041. doi: 10.1016/j.gendis.2023.06.013. eCollection 2024 Jul.
4
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.转谷氨酰胺酶 2-MITF 轴调控皮肤黑色素瘤中的表型转换。
Cell Death Dis. 2023 Oct 28;14(10):704. doi: 10.1038/s41419-023-06223-y.
5
Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.从鼠星形胶质细胞中删除转谷氨酰胺酶 2 可显著提高其在抑制性基质上促进神经突生长的能力。
Int J Mol Sci. 2023 Mar 23;24(7):6058. doi: 10.3390/ijms24076058.
6
Advances in molecular therapies for targeting pathophysiology in spinal cord injury.脊髓损伤病理生理学靶向的分子治疗进展。
Expert Opin Ther Targets. 2023 Mar;27(3):171-187. doi: 10.1080/14728222.2023.2194532. Epub 2023 Apr 5.
7
Microglial transglutaminase 2 deficiency causes impaired synaptic remodelling and cognitive deficits in mice.小胶质细胞转谷氨酰胺酶 2 缺乏导致小鼠突触重塑受损和认知缺陷。
Cell Prolif. 2023 Sep;56(9):e13439. doi: 10.1111/cpr.13439. Epub 2023 Mar 6.
8
Involvement and possible role of transglutaminases 1 and 2 in mediating fibrotic signalling, collagen cross-linking and cell proliferation in neonatal rat ventricular fibroblasts.转谷氨酰胺酶 1 和 2 在介导成纤维细胞信号转导、胶原交联和细胞增殖中的作用及其可能的作用。
PLoS One. 2023 Feb 27;18(2):e0281320. doi: 10.1371/journal.pone.0281320. eCollection 2023.
9
Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation.对星形胶质细胞转谷氨酰胺酶2的药理学抑制作用有助于与组蛋白乙酰化增加相关的神经支持性星形胶质细胞反应性表型的表达。
bioRxiv. 2024 Oct 31:2023.02.06.527263. doi: 10.1101/2023.02.06.527263.
10
Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury.星形胶质细胞转谷氨酰胺酶 2 的缺失或抑制促进脊髓损伤后的功能恢复。
Cells. 2021 Oct 29;10(11):2942. doi: 10.3390/cells10112942.

本文引用的文献

1
The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.凋亡抑制蛋白 BCL2L1/Bcl-xL 被促凋亡蛋白 PMAIP1/Noxa 在神经母细胞瘤中中和,从而决定硼替佐米的敏感性与生存蛋白 MCL1 的表达无关。
J Biol Chem. 2010 Mar 5;285(10):6904-12. doi: 10.1074/jbc.M109.038331. Epub 2010 Jan 5.
2
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.转谷氨酰胺酶 2 通过调节缺氧肿瘤细胞中 caspase 3 和 NF-κB 的活性来抑制细胞凋亡。
Oncogene. 2010 Jan 21;29(3):356-67. doi: 10.1038/onc.2009.342. Epub 2009 Oct 19.
3
Intracellular localization and conformational state of transglutaminase 2: implications for cell death.转谷氨酰胺酶2的细胞内定位与构象状态:对细胞死亡的影响
PLoS One. 2009 Jul 1;4(7):e6123. doi: 10.1371/journal.pone.0006123.
4
Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats.用小干扰RNA早期抑制缺氧诱导因子-1α可减轻大鼠缺血再灌注脑损伤。
Neurobiol Dis. 2009 Mar;33(3):509-17. doi: 10.1016/j.nbd.2008.12.010. Epub 2008 Dec 31.
5
Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription.瘦素在缺血性大脑皮层中被诱导产生,并通过依赖于核因子κB/c-Rel的转录发挥神经保护作用。
Stroke. 2009 Feb;40(2):610-7. doi: 10.1161/STROKEAHA.108.528588. Epub 2008 Nov 20.
6
Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.组织转谷氨酰胺酶诱导基质金属蛋白酶-9的下调。
Biochem Biophys Res Commun. 2008 Nov 28;376(4):743-7. doi: 10.1016/j.bbrc.2008.09.048. Epub 2008 Sep 20.
7
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.转谷氨酰胺酶及转谷氨酰胺酶催化的交联与阿尔茨海默病大脑中的病理损伤共定位。
Brain Pathol. 2009 Oct;19(4):612-22. doi: 10.1111/j.1750-3639.2008.00197.x. Epub 2008 Jul 31.
8
Cell death and proliferation in NF-kappaB p50 knockout mouse after cerebral ischemia.脑缺血后NF-κB p50基因敲除小鼠的细胞死亡与增殖
Brain Res. 2008 Sep 16;1230:281-9. doi: 10.1016/j.brainres.2008.06.130. Epub 2008 Jul 14.
9
HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.在新生大鼠缺氧缺血模型中,抑制缺氧诱导因子-1α可改善新生儿脑损伤。
Neurobiol Dis. 2008 Sep;31(3):433-41. doi: 10.1016/j.nbd.2008.05.020. Epub 2008 Jun 14.
10
Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.转谷氨酰胺酶2可抵御缺血性损伤,与低氧诱导因子1β相互作用,并减弱低氧诱导因子1信号传导。
FASEB J. 2008 Aug;22(8):2662-75. doi: 10.1096/fj.07-097709. Epub 2008 Mar 28.

转谷氨酰胺酶 2 可预防缺血性脑卒中。

Transglutaminase 2 protects against ischemic stroke.

机构信息

Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.

出版信息

Neurobiol Dis. 2010 Sep;39(3):334-43. doi: 10.1016/j.nbd.2010.04.018. Epub 2010 May 6.

DOI:10.1016/j.nbd.2010.04.018
PMID:20451610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2917584/
Abstract

Transglutaminase 2 (TG2) is a multifunctional protein that modulates cell survival and death pathways. It is upregulated in numerous ischemic models, and protects primary neurons from oxygen and glucose deprivation. TG2 binds to the hypoxia inducible factor (HIF) 1beta and decreases the upregulation of hypoxic-induced proapoptotic genes. To investigate the role of TG2 in ischemic stroke in vivo, we used the murine, permanent middle cerebral artery (MCA) ligation model. TG2 mRNA levels are increased after MCA ligations, and transgenic mice that express human TG2 in neurons had significantly smaller infarct volumes than wild type littermates. Further, TG2 translocates into the nucleus within 2h post ligation. Nuclear-localized TG2 is also apparent in human stroke cases. TG2 suppressed the upregulation of the HIF-induced, proapoptotic gene, Noxa. The findings of this study indicate that TG2 plays a role in attenuating ischemic-induced cell death possibly by modulating hypoxic-induced transcriptional processes.

摘要

转谷氨酰胺酶 2(TG2)是一种多功能蛋白,可调节细胞存活和死亡途径。它在许多缺血模型中上调,并保护原代神经元免受缺氧和葡萄糖剥夺。TG2 与缺氧诱导因子(HIF)1β结合,降低缺氧诱导的促凋亡基因的上调。为了研究 TG2 在体内缺血性中风中的作用,我们使用了小鼠永久性大脑中动脉(MCA)结扎模型。MCA 结扎后 TG2mRNA 水平升高,表达人 TG2 的神经元转基因小鼠的梗死体积明显小于野生型同窝小鼠。此外,TG2 在结扎后 2 小时内转移到核内。在人类中风病例中也明显存在核定位的 TG2。TG2 抑制了 HIF 诱导的促凋亡基因 Noxa 的上调。这项研究的结果表明,TG2 通过调节缺氧诱导的转录过程,在减轻缺血诱导的细胞死亡中发挥作用。